Siyan Digital Health Company Profile

Background

Overview

Siyan Digital Health is a California-based company specializing in outpatient mental health services and clinical research. Established in 2012 by Dr. Anish Shah, a psychiatrist, the company has grown to become the largest outpatient psychiatric service in Northern California, serving Sonoma, Napa, Lake, Mendocino, and Marin Counties.

Mission and Vision

Siyan's mission is to improve care for individuals with mental disorders through individualized treatment and patient education. The company envisions accessible, compassionate mental health care for all, emphasizing respect, empathy, and teamwork.

Primary Area of Focus

The company focuses on providing high-quality outpatient mental health services, including medication management, psychotherapy, psychological testing, Transcranial Magnetic Stimulation (TMS), SPRAVATO (Nasal Esketamine), Intensive Outpatient Programs (IOP), and consultation services.

Industry Significance

Siyan Clinical Research, a subsidiary of Siyan Digital Health, is the largest psychiatric research facility in Northern California. Since 2015, it has partnered with leading sponsors to study innovative therapies for conditions such as depression, anxiety, bipolar disorder, PTSD, schizophrenia, and ADHD.

Key Strategic Focus

Core Objectives

Siyan aims to advance the treatment of psychiatric and neurological disorders by conducting science-based clinical trials and providing comprehensive outpatient mental health services.

Specific Areas of Specialization

Clinical Services: Outpatient mental health care, including medication management, psychotherapy, psychological testing, TMS, SPRAVATO, IOP, and consultation services.

Clinical Research: Conducting clinical trials to study innovative therapies for various psychiatric and neurological conditions.

Key Technologies Utilized

Transcranial Magnetic Stimulation (TMS): A non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain.

SPRAVATO (Nasal Esketamine): A nasal spray medication used for treatment-resistant depression.

Primary Markets or Conditions Targeted

Siyan focuses on treating a wide range of psychiatric and neurological conditions, including depression, anxiety, bipolar disorder, PTSD, schizophrenia, and ADHD.

Financials and Funding

Funding History

As of December 2025, specific details regarding Siyan Digital Health's total funds raised, recent funding rounds, and notable investors are not publicly disclosed.

Intended Utilization of Capital

While specific utilization details are not publicly available, it is likely that any capital raised would be directed towards expanding clinical services, enhancing research capabilities, and advancing technological platforms.

Pipeline Development

Key Pipeline Candidates

Siyan Clinical Research is involved in several clinical trials focusing on:

Depression: Investigating new treatments for major depressive disorder.

Anxiety: Studying innovative therapies for anxiety disorders.

Bipolar Disorder: Exploring treatments for bipolar disorder.

PTSD: Conducting trials on therapies for post-traumatic stress disorder.

Schizophrenia: Assessing new treatments for schizophrenia.

ADHD: Researching therapies for attention-deficit/hyperactivity disorder.

Stages of Clinical Trials or Product Development

The company is engaged in various stages of clinical trials, from early-phase studies to late-phase trials, depending on the specific condition and therapy under investigation.

Target Conditions

Siyan's clinical trials target a broad spectrum of psychiatric and neurological conditions, aiming to improve treatment outcomes and patient quality of life.

Relevant Timelines for Anticipated Milestones

Specific timelines for clinical trial milestones are not publicly disclosed. However, the company is committed to advancing research and providing access to emerging treatments.

Technological Platform and Innovation

Proprietary Technologies

Siyan utilizes advanced technologies such as TMS and SPRAVATO to offer innovative treatments for mental health conditions.

Significant Scientific Methods

Clinical Trials: Conducting rigorous, science-based clinical trials to evaluate new therapies.

Telehealth Services: Offering psychiatric services and Intensive Outpatient Program services via telehealth, providing convenient access to care.

Leadership Team

Key Executive Profiles

Dr. Anish Shah: Founder and CEO of Siyan Clinical Corporation. Dr. Shah is a psychiatrist with extensive experience in mental health care and clinical research.

Key Contributions or Roles Within the Company

Dr. Shah has been instrumental in establishing and expanding Siyan's outpatient mental health services and clinical research initiatives, leading the company to become a significant provider in Northern California.

Competitor Profile

Market Insights and Dynamics

The digital health industry, particularly in the realm of mental health services, is experiencing significant growth. Advancements in telehealth, AI-driven diagnostics, and personalized treatment plans are shaping the market landscape.

Competitor Analysis

Siyan's competitors include other outpatient mental health service providers and clinical research organizations in Northern California. Specific competitor names and details are not publicly disclosed.

Strategic Collaborations and Partnerships

Siyan collaborates with leading sponsors and research institutions to conduct clinical trials, enhancing its research capabilities and access to innovative therapies.

Operational Insights

Siyan's operational strategy focuses on providing comprehensive mental health services, integrating clinical care with research to offer evidence-based treatments.

Strategic Opportunities and Future Directions

Strategic Roadmap

Siyan aims to expand its clinical services, enhance research capabilities, and integrate advanced technologies to improve patient care and treatment outcomes.

Future Business Directions

The company is exploring opportunities to broaden its service offerings, including expanding telehealth services and developing new treatment programs.

Opportunities for Expansion

Siyan is considering expanding its geographic footprint to serve additional communities and establishing new partnerships to enhance its service offerings.

Current Strengths Positioning the Company

Siyan's established reputation, comprehensive service offerings, and commitment to research and innovation position it well to achieve its future objectives.